Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion type Assertion NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_head.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion description "[To evaluate the respective roles of residual glomerular filtration (by measuring a specific protein marker, cystatin C), genetic polymorphisms and nutritional status in tHcy blood levels in end-stage renal disease patients (ESRD) under hemodialysis and supplemented with folate, we measured tHcy, folate, vitamin B12 (B12), creatinine, cystatin C, albumin and C-reactive protein and determined the polymorphism of methylenetetrahydrofolate reductase (MTHFR) (C677T and A1289C) and of methionine synthase (MS) (A2756G) in 114 ESRD patients before hemodialysis and 76 control subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_provenance.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion evidence source_evidence_literature NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_provenance.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion SIO_000772 11592445 NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_provenance.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion wasDerivedFrom befree-2016 NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_provenance.
- NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_assertion wasGeneratedBy ECO_0000203 NP332464.RA0sKjX-MjFm4jQU1JlE_cmOvuiajZiOUE5R2y0_icBVU130_provenance.